RxDoctor Payments Data

Sitalakshmi Iyer, MD

Nephrology · Salem, ORNPI 1023306628

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $360 of the $460 with a category attached, or 78.3%. 8 manufacturers reported payments, led by Vantive US Healthcare LLC at 28.0% of the total. 2025 is the largest year on record at $272, 2.7 times the $100 reported in 2019.

$460in general payments, 2019–2025

Across 9 payments — averaging $51.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vantive US Healthcare LLC$129
  • Fresenius USA Marketing, Inc.$110
  • Mallinckrodt Enterprises LLC$100
  • Vifor Pharma, Inc.$44
  • GSK$24
  • Mallinckrodt Hospital Products Inc.$20
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$36078%
  • Education$10022%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$460 in reported general payments places this provider in the 65th percentile of 120 nephrology providers in Oregon.

See all nephrology providers in Oregon

Medicare billing

Part B allowed, 2024
$113,516
Medicare patients
228
Services billed
800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin24$36,910
LokelmaSodium Zirconium Cyclosilicate21$13,013
Sevelamer Carbonate47$8,252
Calcium Acetate53$4,613
Potassium Chloride88$2,879
Midodrine Hcl31$1,951
Torsemide83$1,854
Losartan Potassium162$1,655
Hydralazine Hcl93$1,183
Nifedipine ErNifedipine53$1,172
Carvedilol114$1,129
Calcitriol65$1,042
Amlodipine Besylate144$1,010
Labetalol Hcl29$855
Metoprolol Succinate50$818

Paid to pharmacies, not to this prescriber.

Other nephrology in Salem

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →